Cell & Gene Therapy
CAR-T and gene therapies are redefining the treatment landscape. Omega supports your ATMP programs at every stage with a federated manufacturing network structure, end-to-end clinical operations expertise, and an integrated ecosystem.
CAR-T Therapies
End-to-end CAR-T trial support from apheresis coordination to post-infusion CRS/ICANS monitoring, long-term follow-up, and release testing.
Learn More →Gene Therapies
AAV, lentiviral, and mRNA-based therapies; preclinical biodistribution, immunogenicity monitoring, patient selection, and long-term safety follow-up.
Learn More →Federated Manufacturing Network
Multi-site distributed manufacturing nodes; harmonized processes, a centralized quality layer, and end-to-end Chain of Identity traceability.
Learn More →Let’s advance your ATMP program together
Speak with our team about our CAR-T, gene therapy, and manufacturing network capabilities.
Contact Us